Teva Pharmaceutical Industries (TEVA, $13.81) was one of top quarterly gainers, jumping +1 to $13.81 per share. A.I.dvisor analyzed 292 stocks in the Pharmaceuticals: Other Industry over the last three months, and discovered that of them (5) charted an Uptrend while of them (4) trended down. A.I.dvisor found 275 similar cases when TEVA's price went up within three months. In out of those 275 cases, TEVA's price went down during the following month. Based on these historical data, A.I. thinks the odds of an Uptrend reversal for TEVA are